Ajay Verma

Ajay has over a decade of experience leading teams in the pharmaceutical industry at Novartis, Biogen, United Neuroscience, and most recently Codiak Biosciences. He bring deep expertise in clinical trial design and execution as well as in drug development in the CNS space. While at Biogen, he previously oversaw the development of Aducanumab though phase 2 development.